The purpose of this study is to develop a new tool that uses information collected before life-sustaining treatments are withdrawn to better predict whether a patient will die within the time needed for organ donation to be possible. The tool created should help improve planning for organ donation and provide families and healthcare teams with more accurate information.
Age ≥ 19;
Eligible for DCD
concurrent vasopressor doses of norepinephrine >0.05 mcg/kg/min (or dose equivalent)
PaO2/FiO2 ratio <150 mmHg
complete high cervical spinal cord injury (C5 and above)
cardiac support devices (e.g., ECMO, balloon pump, ventricular assist device)
University of British Columbia
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator